Who owns iBio, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IBIO from SEC Form 13F filings across 59 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 59 institutions disclosed 37.5M shares of iBio, Inc. worth $44.3M — about 24.7% of shares outstanding; the largest disclosed holder is SILVERARC CAPITAL MANAGEMENT, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
59
13F holders
$44.3M
value, 2026 filers
24.7%
of shares outstanding (37.5M sh)
11
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of IBIO's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | SILVERARC CAPITAL MANAGEMENT, LLC | 5.4M | $6.3M | 0.7% | 3.5% | +52.2% |
| 2 | Affinity Asset Advisors, LLC | 4.1M | $4.9M | 0.2% | 2.7% | +3.1% |
| 3 | Cormorant Asset Management, LP | 3.6M | $4.2M | 0.3% | 2.4% | 0.0% |
| 4 | Vestal Point Capital, LP | 2.6M | $3.1M | 0.1% | 1.7% | 0.0% |
| 5 | Woodline Partners LP | 2.2M | $2.6M | 0.0% | 1.5% | +26.0% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 2.1M | $2.5M | 0.0% | 1.4% | 0.0% |
| 7 | Frazier Life Sciences Management, L.P. | 2.0M | $2.3M | 0.1% | 1.3% | 0.0% |
| 8 | Balyasny Asset Management L.P. | 1.6M | $1.9M | 0.0% | 1.1% | +36.0% |
| 9 | Ensign Peak Advisors, Inc | 1.6M | $1.8M | 0.0% | 1% | -14.6% |
| 10 | BANK OF AMERICA CORP /DE/ | 1.5M | $1.8M | 0.0% | 1% | +32.7% |
| 11 | MILLENNIUM MANAGEMENT LLC | 1.4M | $1.7M | 0.0% | 0.9% | -13.8% |
| 12 | Ikarian Capital, LLC | 957,062 | $1.1M | 0.1% | 0.6% | 0.0% |
| 13 | Sio Capital Management, LLC | 904,268 | $1.1M | 0.2% | 0.6% | 0.0% |
| 14 | Atom Investors LP | 881,558 | $1.0M | 0.1% | 0.6% | +768.0% |
| 15 | MARSHALL WACE, LLP | 766,195 | $904,110 | 0.0% | 0.5% | -15.3% |
| 16 | RENAISSANCE TECHNOLOGIES LLC | 688,400 | $812,312 | 0.0% | 0.5% | +239.4% |
| 17 | CITADEL ADVISORS LLC | 666,171 | $786,082 | 0.0% | 0.4% | -51.9% |
| 18 | GEODE CAPITAL MANAGEMENT, LLC | 525,983 | $620,811 | 0.0% | 0.3% | +5.0% |
| 19 | Walleye Capital LLC | 400,043 | $472,051 | 0.0% | 0.3% | -20.1% |
| 20 | ADAR1 Capital Management, LLC | 375,531 | $443,127 | 0.0% | 0.2% | 0.0% |
| 21 | Sofinnova Investments, Inc.NEW | 371,700 | $438,606 | 0.0% | 0.2% | new |
| 22 | BlackRock, Inc. | 291,450 | $343,911 | 0.0% | 0.2% | +20.4% |
| 23 | VANGUARD FIDUCIARY TRUST CO | 286,875 | $338,513 | 0.0% | 0.2% | 0.0% |
| 24 | BOOTHBAY FUND MANAGEMENT, LLC | 254,412 | $300,206 | 0.0% | 0.2% | 0.0% |
| 25 | NOESIS CAPITAL MANGEMENT CORP | 249,000 | $293,820 | 0.0% | 0.2% | -38.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.